India gives emergency use approval to Eli Lilly’s Covid antibody drug

  • 3 years ago
US drugmaker Eli Lilly and Co today said its antibody-drug combination has received an emergency use approval in India for the treatment of mild to moderate COVID-19 case.

Recommended